Botulinum Toxin Injection in the UES for R-CPD

NCT06356025 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Retrograde Cricopharyngeus Dysfunction

Interventions

DRUG: botulinum toxin type A
DRUG: Sodium Chloride 0.9% Inj

Sponsor

AZ Delta

Collaborators

[object Object]